RESUMO
OBJECTIVES: Hashimoto's thyroiditis (HT) is characterized by lymphocytic thyroid infiltration. Gradual thyroid failure can occur due to thyroid cell apoptosis. Rarely neurological autoimmunity due to glutamic acid decarboxylase (GAD) antigen can co exist with HT. CASE PRESENTATION: A seven-year-old male presented with tiredness, weight loss, frequent falls, tachycardia, firm thyromegaly, and abnormal gait. Biochemical markers and thyroid ultrasound (TUS) showed autoimmune hyperthyroidism. Methimazole (MMI) was started and continued for 2.2 years. MRI brain was normal and neurological symptoms resolved. At nine years, he became hypothyroid and levothyroxine (LT4) was started. Serial TUS showed progressive thyroid atrophy. At 14.8 years, he developed epilepsy and fourth cranial nerve palsy, and diagnosed with GAD-65 central nervous system disease. At 15.3 years, TUS showed complete atrophy of right lobe with involuting left lobe volume. CONCLUSIONS: This is an unusual form of atrophic thyroiditis (AT) with coexisting neurological autoimmunity. GAD-65 CNS autoimmunity should be considered in children with AT presenting with neurological signs.
Assuntos
Doenças Autoimunes do Sistema Nervoso/diagnóstico , Glutamato Descarboxilase/imunologia , Glândula Tireoide/patologia , Tireoidite Autoimune/diagnóstico , Adolescente , Atrofia/complicações , Atrofia/diagnóstico , Doenças Autoimunes/diagnóstico , Doenças Autoimunes/etiologia , Doenças Autoimunes do Sistema Nervoso/etiologia , Criança , Diagnóstico Diferencial , Humanos , Masculino , Glândula Tireoide/diagnóstico por imagem , Glândula Tireoide/imunologia , Tireoidite Autoimune/complicações , Tireoidite Autoimune/patologia , Estados UnidosRESUMO
Mutations of the Surfactant Protein C (SPC) gene (SFTPC) have been associated with childhood interstitial lung disease (chILD) with variable age of onset, severity of lung disease, and outcomes. We report a novel mutation in SFTPC [c.435G->A, p.(Gln145)] that was associated with onset of symptoms in early infancy, progressive respiratory failure with need for prolonged mechanical ventilatory support, and eventual lung transplant at 1 year of age. While the mutation was not predicted to alter the amino acid sequence of the SP-C precursor protein, analysis of SP-C transcripts demonstrated skipping of exon 4. Because of limited data about the outcomes of infants with SFTPC mutations, we conducted a systematic review of all the SFTPC mutations reported in the literature in order to define their presenting features, clinical and radiologic features, and outcomes. Further advances in our understanding of chILD and creation of an international registry will help to track these patients and their outcomes. Pediatr Pulmonol. 2017;52:57-68. © 2016 Wiley Periodicals, Inc.
Assuntos
Doenças Pulmonares Intersticiais/genética , Mutação , Proteína C Associada a Surfactante Pulmonar/genética , Insuficiência Respiratória/genética , Criança , Feminino , Humanos , Lactente , Doenças Pulmonares Intersticiais/diagnóstico , Masculino , Insuficiência Respiratória/diagnósticoAssuntos
Diabetes Mellitus Tipo 1/complicações , Fácies , Hepatomegalia/complicações , Insulina/uso terapêutico , Hepatopatias/complicações , Puberdade Tardia/complicações , Vitamina K/uso terapêutico , Adolescente , Diabetes Mellitus Tipo 1/tratamento farmacológico , Diagnóstico Diferencial , Feminino , Hepatomegalia/diagnóstico por imagem , Hepatomegalia/tratamento farmacológico , Humanos , Hipoglicemiantes/uso terapêutico , Fígado/diagnóstico por imagem , Hepatopatias/diagnóstico por imagem , Hepatopatias/tratamento farmacológico , Síndrome , Ultrassonografia/métodos , Vitaminas/uso terapêuticoRESUMO
Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are markers of inflammatory conditions and have been used extensively by clinicians both in outpatient and inpatient settings. It is important to understand the physiologic principles behind these two tests so clinicians may use them appropriately. For example, fibrinogen (for which ESR is an indirect measure) has a much longer half-life than CRP, making ESR helpful in monitoring chronic inflammatory conditions, whereas CRP is more useful in diagnosis as well as in monitoring responses to therapy in acute inflammatory conditions, such as acute infections. Many factors can result in falsely high or low ESR and CRP levels, and it is important to take note of these. Therefore, if used wisely, ESR and CRP can be complementary to good history taking and physical examination in the diagnosis and monitoring of inflammatory conditions.